Dr. Christopher Morse is a Associate Visiting Surgeon in the Dept of Surgery and an Assistant Professor of Surgery at Harvard Medical School. He serves as the Co-Director of the Gastroesophageal Surgery Program.
Dr. Morse graduated from Columbia University College of Physicians and Surgeons. He did both his surgical residencies at the MGH, first in general surgery and then in Cardiothoracic Surgery. Dr. Morse went on complete a second fellowship in minimally invasive thoracic surgery with a particular emphasis on esophageal surgery. He is Board certified in both Surgery and Thoracic Surgery.
Dr. Morse is clinically very active and sees new patients weekly. His clinical interests revolve around malignancies of the chest, especially lung and esophageal cancer, as well as the treatment a variety of benign esophageal conditions, including achalasia, paraesophageal hernia and gastroesophageal reflux disease. Dr. Morse has taken a lead role in the development of a minimally invasive esophagectomy program at MGH. This work has led to a number of manuscripts including a direct comparison of open vs. minimally invasive esophagectomy. He also performs the minimally invasive Transoral Incisionless Fundoplication (TIF) procedure to treat GERD.
Dr. Morse serves as the co-director of the MGH Gastroesophageal Surgery program and participates on workforces in several national thoracic societies.